Results 71 to 80 of about 212,254 (386)

Current concepts of chronic gastritis and gastropathies: new international consensus RE.GA.IN

open access: yesGastroenterologìa
Recent decades have been marked by several important milestones in the field of gastritis. New epidemiological reports were received, especially from countries with a high incidence of gastric cancer, and H.pylori infection was recognized as the most ...
S.M. Tkach   +4 more
doaj   +1 more source

Autoimmune Gastritis [PDF]

open access: yesArchives of Pathology & Laboratory Medicine, 2019
Context.— Autoimmune gastritis (AG) is a corpus-restricted chronic atrophic gastritis associated with intrinsic factor deficiency, either with or without pernicious anemia. Autoimmune gastritis is a microscopic disease because patients present with no or vague symptoms, and clinicians rarely find endoscopic changes.
Sara N, Hall, Henry D, Appelman
openaire   +2 more sources

Intrafraction motion and impact of margin reduction for MR‐Linac online adaptive radiotherapy for pancreatic cancer treatments

open access: yesJournal of Medical Radiation Sciences, Volume 72, Issue 1, Page 17-24, March 2025.
This analysis included quantification of intrafraction motion in pancreas stereotactic ablative radiotherapy treated on the MR‐Linac, leading to the development of adjusted (PTV) margins. Intrafraction motion indicated an average target displacement of 1–3 mm, resulting in an adjusted PTV margin of 2 mm in the right–left and superior–inferior ...
Ashleigh Fasala   +6 more
wiley   +1 more source

Clinical comparative study of different scoring in directly judging Helicobacter pylori current infection under white light endoscopy [PDF]

open access: yesXin yixue
Objective To evaluate the consistency between Kyoto classification scoring of gastritis and modified Kyoto classification scoring of gastritis in directly determining Helicobacter pylori (Hp) infection under white light endoscopy by endoscopists with 13C
YU Huimin, LI Bo, LU Ping
doaj   +1 more source

Previous Helicobacter pylori infection–induced atrophic gastritis: A distinct disease entity in an understudied population without a history of eradication

open access: yesHelicobacter, 2019
Individuals with chronic atrophic gastritis who are negative for active H. pylori infection with no history of eradication therapy have been identified in clinical practice.
H. Kishikawa   +8 more
semanticscholar   +1 more source

Genome sequence of Helicobacter heilmannii sensu stricto ASB1 isolated from the gastric mucosa of a kitten with severe gastritis [PDF]

open access: yes, 2012
Here we report the genome sequence of Helicobacter heilmannii sensu stricto ASB1 isolated from the gastric mucosa of a kitten with severe gastritis.
Deforce, Dieter   +6 more
core   +2 more sources

Characterization of pediatric eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis in a nationwide cohort

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Nonesophageal eosinophilic gastrointestinal disorders (non‐EoE EGIDs) are rare, underrecognized inflammatory diseases of the gastrointestinal (GI) tract, especially in children. Their clinical heterogeneity and lack of specific biomarkers contribute to diagnostic delays and therapeutic challenges.
Sara Renzo   +16 more
wiley   +1 more source

A Computer-Assisted Diagnosis System for the Detection of Chronic Gastritis in Endoscopic Images Using A Novel Convolution and Relative Self-Attention Parallel Network

open access: yesIEEE Access, 2023
Chronic gastritis mainly includes chronic non-atrophic gastritis (CNAG), autoimmune gastritis (AIG), and type B gastritis. Early detection of AIG and type B gastritis will help identify high-risk groups for gastric cancer and prevent the development of ...
Dawei Gong   +5 more
doaj   +1 more source

Immunotherapy-Related Gastritis in Small Cell Lung Cancer Treatment With Durvalumab-A Case Report. [PDF]

open access: yesCancer Rep (Hoboken)
ABSTRACT Background Durvalumab is a PD‐L1 inhibitor that triggers a blockade resulting in enhanced anti‐tumor responses related to increased T‐cell activation. There is potential for numerous immune‐related adverse events (irAEs) with this treatment, most of which have been shown to be effectively managed with high‐dose steroids.
Cavaliere MC, Spadafora S, Febbraro M.
europepmc   +2 more sources

Nonesophageal Eosinophilic Gastrointestinal Disorders: Clinical Care and Future Directions [PDF]

open access: yes, 2018
Eosinophilic gastrointestinal disorders are a set of conditions with a wide range of clinical manifestations and treatment modalities. The disorders are suspected to result from an abnormal inflammatory response to allergen(s), and individuals may ...
Gupta, Sandeep K., Naramore, Sara
core   +1 more source

Home - About - Disclaimer - Privacy